Evaluation of surufatinib, an orally available VEGFR, FGFR1 and CSF-1R inhibitor, in combination with immune checkpoint blockade or chemotherapy in preclinical tumor models

2020 ◽  
Vol 138 ◽  
pp. S25
Author(s):  
M. Cheng ◽  
S. Fan ◽  
R. Tang ◽  
W. Zhang ◽  
J. Hu ◽  
...  
2021 ◽  
Vol 13 (611) ◽  
Author(s):  
Marcel André Schneider ◽  
Laura Heeb ◽  
Michal Mateusz Beffinger ◽  
Stanislav Pantelyushin ◽  
Michael Linecker ◽  
...  

2020 ◽  
Vol 15 (5) ◽  
pp. 1628-1648 ◽  
Author(s):  
Rachael M. Zemek ◽  
Vanessa S. Fear ◽  
Cath Forbes ◽  
Emma de Jong ◽  
Thomas H. Casey ◽  
...  

2018 ◽  
Vol 80 (1) ◽  
pp. 51-55
Author(s):  
Ai KAJITA ◽  
Osamu YAMASAKI ◽  
Tatsuya KAJI ◽  
Hiroshi UMEMURA ◽  
Keiji IWATSUKI

Sign in / Sign up

Export Citation Format

Share Document